New Immunotherapy against various tumors such as Lung Cancer, including non-small cell lung carcinoma (NSCLC)

摘要

The present Invention relates to Peptides, Nucleic acids and Cells for use in immunotherapeutic methods.Specifically, the present Invention relates to Cancer Immunotherapy.The Invention relates also to Peptide epitopes for Cytotoxic T lymphocytes (CTL) associated with tumorAlone or in combination with other tumor Associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate antitumor immune responses.More specifically, The Invention relates to peptides comprising the sequence SEQ ID no: 5 or 80% homologous variants in this